​

AC Immune (ACIU) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

ACIU Stock Forecast

AC Immune (ACIU) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $8.33, with a high of $10.00 and a low of $7.00. This represents a 213.16% increase from the last price of $2.66.

$2 $3 $4 $5 $6 $7 $8 $9 $10 High: $10 Avg: $8.33 Low: $7 Last Closed Price: $2.66

ACIU Stock Rating

AC Immune stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (88.89%), 1 Hold (11.11%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 0 1 8 Strong Sell Sell Hold Buy Strong Buy

ACIU Price Target Upside V Benchmarks

TypeNameUpside
StockAC Immune213.16%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$7.00
Last Closing Price$2.66$2.66$2.66
Upside/Downside--163.16%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26-4---4
Aug, 26-4---4
Jul, 26-4---4
Jun, 26-4---4
May, 26-4---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 13, 2026Lucy CodringtonJefferies$7.00$3.01132.56%163.16%
May 30, 2024Thomas ShraderBTIG$8.00$3.97101.51%200.75%
Jul 11, 2022Leerink Partners$10.00$3.35198.51%275.94%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 24, 2026H.C. WainwrightBuyBuyhold
Jul 01, 2026H.C. WainwrightBuyBuyhold
Mar 13, 2026JefferiesBuyBuyhold
Sep 18, 2024H.C. WainwrightBuyBuyhold
May 30, 2024BTIGBuyinitialise
Jul 11, 2022SVB LeerinkOutperformOutperformhold

Financial Forecast

EPS Forecast

$-10 $-6 $-2 $2 $6 $10 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.97$-0.85$-0.64-----
Avg Forecast$-0.63$-0.88$-0.71$-0.54$-0.25$-0.24$0.62$0.85
High Forecast$-0.08$-0.09$-0.63$-0.51$1.29$0.67$9.12$1.69
Low Forecast$-1.03$-1.66$-0.78$-0.56$-2.75$-0.87$-7.66$-0.18
Surprise %53.97%-3.41%-9.86%-----

Revenue Forecast

$0 $80M $160M $240M $320M $400M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$3.94M$14.80M-----
Avg Forecast$28.25M$5.58M$10.19M$27.09M$56.96M$66.35M$172.18M$201.19M
High Forecast$41.99M$9.44M$11.04M$27.74M$100.42M$69.18M$303.54M$354.67M
Low Forecast$9.22M$1.72M$9.35M$26.57M$3.86M$63.51M$11.66M$13.62M
Surprise %--29.53%45.19%-----

Net Income Forecast

$-1B $-600M $-200M $200M $600M $1B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-73.00M$-70.75M$-54.23M-----
Avg Forecast$-53.55M$-74.13M$-59.72M$-45.51M$-24.87M$-24.29M$11.46M$71.67M
High Forecast$-6.66M$-7.49M$-53.58M$-43.34M$109.58M$56.57M$772.66M$142.75M
Low Forecast$-87.40M$-140.66M$-65.87M$-47.67M$-232.52M$-74.05M$-648.74M$-15.19M
Surprise %36.30%-4.56%-9.19%-----

ACIU Forecast FAQ

Is AC Immune stock a buy?

AC Immune stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that AC Immune is a favorable investment for most analysts.

What is AC Immune's price target?

AC Immune's price target, set by 9 Wall Street analysts, averages $8.33 over the next 12 months. The price target range spans from $7 at the low end to $10 at the high end, suggesting a potential 213.16% change from the previous closing price of $2.66.

How does AC Immune stock forecast compare to its benchmarks?

AC Immune's stock forecast shows a 213.16% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for AC Immune over the past three months?

  • September 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is AC Immune’s EPS forecast?

AC Immune's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.54, marking a -15.62% decrease from the reported $-0.64 in 2023. Estimates for the following years are $-0.25 in 2025, $-0.24 in 2026, $0.62 in 2027, and $0.85 in 2028.

What is AC Immune’s revenue forecast?

AC Immune's average annual revenue forecast for its fiscal year ending in December 2024 is $27.09M, reflecting a 83.03% increase from the reported $14.8M in 2023. The forecast for 2025 is $56.96M, followed by $66.35M for 2026, $172.18M for 2027, and $201.19M for 2028.

What is AC Immune’s net income forecast?

AC Immune's net income forecast for the fiscal year ending in December 2024 stands at $-45.506M, representing a -16.09% decrease from the reported $-54.233M in 2023. Projections indicate $-24.874M in 2025, $-24.287M in 2026, $11.46M in 2027, and $71.67M in 2028.